Life Whisperer, an AI startup in the fertility sector, has won two National iAwards (Merit): Start Up of the Year, and Big Data / Machine Learning Innovation of the Year. The awards have also kicked off Life Whisperer’s search for Series A investment to expedite the first commercial release of their cloud-based tool for IVF clinics, and to expand their business overseas.
iAwards is the premier technology awards platform in Australia delivering the most comprehensive awards program which recognizes the achievements and innovation made in ICT across all facets of the economy. The iAwards honors companies at the cutting edge of technology innovation. The key goal of the iAwards is to discover, recognize and reward the ICT innovations that have the potential to, or are already having a positive impact on the community – at home, in the office and on a global scale.
Life Whisperer won the awards for its innovation that applies non-invasive AI-driven image analysis, including deep learning and computer vision, to conduct morphological assessment of embryos to assist in the selection of viable embryos for IVF implantation. The technology aims to improve successful outcomes for IVF couples, which currently have low success rates.
Co-founder and inventor of the technology Dr Jonathan Hall said “We are delighted to have won these two prestigious awards given we had only just launched Life Whisperer 6 months ago. Our partnership with one of the largest IVF clinics in Australia, ASX-listed Monash IVF, has allowed us to accelerate the development of our technology, in the hope that we can have a positive impact on families undergoing IVF in the near future”.
Life Whisperer’s co-founder Dr Michelle Perugini said “Preliminary validation of our technology is already showing great results in identifying viable embryos. Based on these results, we are now actively seeking Series A investment, and are confident we can create a global disruptive business in the fertility sector.”
For more information email Info@LifeWhisperer.co or contact Dr Michelle Perugini on +61 412 396 960